Literature DB >> 9152791

Temporal relationship between cancers of the lung and upper aerodigestive tract.

W C Hsieh1, Y M Chen, R P Perng.   

Abstract

We retrospectively reviewed the chart records at the Veterans General Hospital-Taipei for the period between January 1985 and December 1994 to examine the temporal relationship between cancers of the lung and upper aerodigestive tract. A total of 56 patients (54 males, 2 females) with histocytologically proven double primary cancers, with either lung cancer or upper aerodigestive tract cancers appearing first, were found. Squamous cell carcinoma was the most frequent histologic type of lung cancer (squamous 57%, adenocarcinoma 27%, poorly differentiated carcinoma 9%, small cell lung cancer 7%). The incidence of lung cancer patients with upper aerodigestive tract cancer was 0.9% (56/6412). There was no significant difference in the occurrence of upper aerodigestive tract cancer between non-small cell and small cell lung cancer (P > 0.05). However, the incidence of squamous cell lung cancer with upper aerodigestive tract cancer was higher than that of non-squamous cell lung cancer (P < 0.05). With regard to the location of lung cancer, the right lung was more commonly affected than the left (P < 0.001). The locations of upper aerodigestive tract cancers in these lung cancer patients were as follows: larynx 24, nasopharynx 11, esophagus 10, hypopharynx 4, pharyngeal tonsils 2, oral cavity 5. Most upper aerodigestive tract cancers were diagnosed before lung cancer (36/56, 64%), and lung cancer was diagnosed within 3 years in more than half of cases after the diagnosis of upper aerodigestive tract cancer (58.3%). Most lung cancers that preceded upper aerodigestive tract cancer were at an early stage at diagnosis (stage I 4, stage Illa 1), whereas the others, appearing either synchronously or after the diagnosis of upper aerodigestive tract cancer, were mostly at the late stage. There was no difference in survival between lung cancer patients with upper aerodigestive tract cancer and those without (P > 0.05).

Entities:  

Mesh:

Year:  1997        PMID: 9152791     DOI: 10.1093/jjco/27.2.63

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

1.  Synchronous Primary Endometrial Carcinoma and Metastatic Malignant Melanoma in Cervical Lymph Node.

Authors:  Kanwardeep Tiwana; Sarita Nibhoria; Manmeet Kaur; Saloni Bansal
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Synchronous Oral and Breast Malignancies: A Rare Presentation.

Authors:  Sonam Sharma; Poonam Khambra; Ashish Kumar Mandal
Journal:  Indian J Surg Oncol       Date:  2017-03-28

3.  Hereditary factors in multiple primary malignancies associated with lung cancer.

Authors:  Shuji Haraguchi; Kiyoshi Koizumi; Masafumi Hioki; Takao Hisayoshi; Tomomi Hirata; Kazuo Shimizu
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

4.  Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.

Authors:  Eui Bae Kim; Yong Park; Seh Jong Park; Dae Sik Kim; Jee Won Kim; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim; Sang Won Shin; Chul Yong Kim; Kwang-Yoon Jung
Journal:  Cancer Res Treat       Date:  2008-12-31       Impact factor: 4.679

5.  Dual primary malignancy: a rare organ combination.

Authors:  Preetam Acharya; Anand Ramakrishna; Tanuj Kanchan; Rahul Magazine
Journal:  Case Rep Pulmonol       Date:  2014-10-07

6.  Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.

Authors:  Shan Shan; Jun She; Zhi-Qiang Xue; Chun-Xia Su; Shen-Xiang Ren; Feng-Ying Wu
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

7.  Double primary bronchogenic carcinoma of the lung and papillary thyroid carcinoma: a case report.

Authors:  Jen-Hsun Cheng; Ying-Chieh Huang; Chih Kuo; Yih-Shyong Lai; Tzu-Ching Wu; Thomas Chang-Yao Tsao; Shi-Ping Luh; Chong-Bin Tsai
Journal:  J Med Case Rep       Date:  2008-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.